Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: A Study of Radiation With Sorafenib in Advanced Cancer [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 trial evaluating the combination of radiation therapy with sorafenib in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer | Phase 1 | Status: COMPLETED